share_log

Market-Moving News for June 17th

Market-Moving News for June 17th

6月17日市场资讯
Benzinga ·  06/17 08:40

BBY: 4% | UBS Upgrades Best Buy Co to Buy, Raises Price Target to $106

百思买:4% | 瑞银将百思买评级升至买入,将价格目标提高至106美元

ZYME: 13% | Zymeworks shares are trading higher after the FDA cleared the company's Investigational New Drug application for Zw171 for mesothelin-expressing cancers, with the company expecting to initiate clinical development during 2024.

zymeworks:13% | 经FDA审核后,Zymeworks公司的针对表达介质为mesothelin的肿瘤的新药Investigational New Drug已获批准,公司计划在2024年开始临床试验

QTTB: 9% | Q32 Bio shares are trading higher after Guggenheim initiated coverage with a Buy rating and a $100 price target.

Q32 Bio:9% | Q32 Bio股票在Guggenheim的买入评级和100美元的价格目标下交易较高

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发